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Persons with trisomy 21 (Down syndrome) present different phenotypes, including early neurodegeneration, which is prominent in the 
brain olfactory areas, and olfactory deficit. The use of in vivo techniques in animal models allows to characterize and follow up these 
slowly developing phenomena. We explored by means of magnetic resonance imaging the olfactory bulb of the Ts65Dn mouse, an 
established model of Down syndrome, searching for possible syndrome‑related changes. In vivo imaging provided a first glimpse of the 
trisomic olfactory bulb as compared to euploid one. The olfactory bulb volume was smaller in trisomic mice, suggesting that changes 
in olfactory bulb may be apparent already in the young adult (2‑ to 8‑month‑old) mice, which are amenable to follow‑up in vivo. These 
findings lead the way to future work aimed at characterizing the Down syndrome‑related development of morphological alterations in 
the olfactory bulb and relating them to changes in olfactory performance, which were detected in this mouse model.
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INTRODUCTION
Down syndrome (DS), which affects approximately 
1 out of 700 live births (Parker et al., 2010) is character‑
ized by trisomy of chromosome 21. DS is characterized 
by several conditions including intellectual disabili‑
ty, craniofacial alterations, congenital heart disease, 
early onset Alzheimer’s disease, gastrointestinal dis‑
orders, low muscle strength (Korenberg et al., 1994). 
Olfactory dysfunction has been consistently found in 
DS (Murphy et al., 1996; Cecchini et al., 2016) together 
with age‑associated development of Alzheimer’s dis‑
ease neuropathology in the olfactory system, starting 
from the entorhinal and trans‑entorhinal areas (Price 
et al., 1991), as well as neurodegenerative pathology 
(Mann et al., 1986). The olfactory bulb (OB) is the first 
central relay station of the peripheral olfactory neu‑
rons playing a key role in olfactory processing (Mori et 
al., 1999). In the OB, multiple types of neurons network 
to process information and transmit it to the olfactory 
cortex. Despite several techniques have been used to 
investigate the DS brain in vivo (review in Neale et al., 
2017), information on OB status in living persons with 
DS is quite limited.
The Ts65Dn mouse is one of the most extensively 
studied animal models of DS. It presents segmental 
trisomy for chromosome 16 and involves roughly half 
of human chromosome 21 orthologs (Davisson et al., 
1993). In the Ts65Dn mouse, smell impairments appear 
in adulthood (Bianchi et al., 2014) since reduced neuro‑
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genesis takes place: this has been suggested to underlie 
hypocellularity of the OB, ultimately leading to deficit 
in olfactory learning through a reduction in the num‑
ber of new granule neurons migrating to the OB from 
the subventricular zone. This has been challenged by 
others (López‑Hidalgo et al., 2016). Similar alterations 
have also been observed in persons with DS. Moreover, 
Ts65Dn mice present impaired refinement of synaptic 
connections by olfactory neurons in the OB (William 
et al., 2017). Accordingly, investigating the OB in the 
Ts65Dn mouse is relevant to clarify the mechanisms of 
olfactory impairment in DS. Magnetic resonance imag‑
ing (MRI) is a recognized, powerful and non‑invasive 
tool to investigate the in vivo morphology and function 
of organs in both humans and experimental animals. 
Using the same technology, MRI findings in experi‑
mental animals can be easily translated to the patient. 
In this work we examined trisomic and euploid Ts65Dn 
mice by means of MRI to highlight possible DS‑related 
changes in the OB. In particular, we focused on an MRI 
protocol that could provide structural and anatomi‑
cal insight in the DS‑related changes of the OB, while 
being compatible with in vivo examination in a fragile 
animal model.
METHODS
Ts65Dn (strain: B6EiC3Sn.BLia‑Ts(17<16>)65Dn/DnJ) 
breeder mice were obtained from the Jackson Labora‑
tory, ME, USA. The colony was maintained by breeding 
trisomic female mice to euploid B6EiC3Sn.BLiAF1/J 
males. Pups were weaned at 21 days of age. Tissue for 
genotyping was obtained from tail clips in p11 mice. 
Genotyping was accomplished by Mmu17 translocation 
breakpoint separated PCR. Adult (2‑8 months of age) 
male Ts65Dn mice (8 trisomic and 8 euploid) were used 
in this work. Male mice were chosen for this study be‑
cause of lack of variability associated with the estrous 
cycle. Mice were housed in groups of 3‑4 by genotype 
and maintained under standard conditions (24±1°C 
temperature, 60±15% relative humidity, and 12 h light/
dark cycle) and fed ad libitum with standard commer‑
cial chow. 
The experimental protocol was reviewed and autho‑
rized according to EU Directive 2010/63/EU by the Ital‑
ian Ministry of Health (ref.: 538/2015‑PR).
For MRI, mice were anesthetized by inhalation of 
a mixture of air and O2 containing 0.5–1% isoflurane and 
placed prone with their head in stereotactic position. 
Images were acquired using a Biospec Tomograph 
(Bruker, Karlsruhe, Germany) equipped with a 4.7 T, 
33 cm bore horizontal magnet (Oxford Ltd, Oxford, 
UK). A double coil configuration was used: the ex‑
citation r.f. pulses were applied trough a 7.2 cm bird 
cage volume coil, while the signal was received through 
a 2‑channel surface coil optimized for the mouse brain 
(Bruker). After a sagittal scout image, 6‑7 contiguous 0.5 
mm‑thick slices were acquired through the whole OB 
using a RARE T2‑weighed sequence with TR (repetition 
time) = 5000 ms, TE (echo time) = 72 ms, FOV (field of 
view) = 2 × 2 cm2, NEX (number of average) = 10, matrix 
size = 256 × 192, zero‑filled at 256 × 256, corresponding 
to an in plane resolution of 78 × 78 μm2. These images 
were used for calculation of OB volume. For morphom‑
etry, the free ImageJ software (National Institutes of 
Health, USA) was used. The OB area was measured in 
each 0.5‑mm thick axial section containing the OB. Ar‑
eas were expressed in mm2 and volumes consequently 
calculated according to Cavalieri’s principle (Roberts et 
al., 1993). In order to ensure consistence, one operator 
blind to mouse genetics performed all morphometric 
measurements. Further on, 1 mm‑thick slices of the 
whole OB were acquired using a multiecho spin‑echo 
sequence, with 10 echoes, TR of 2600 ms, and TE rang‑
ing from 20 to 200 ms, for generating quantitative T2 
mapping (Bontempi et al., 2018). T2 maps were gener‑
ated with Paravision 5.1 (Bruker, Karlsruhe, Germany).
Diffusion tensor imaging (DTI) is based on the ob‑
servation of water molecule diffusivity in the brain; DTI 
is especially employed to characterize the orientation 
and integrity of the white matter (Basser et al., 2002; Le 
Bihan et al., 2001). DTI images were acquired with an 
Echo Planar Imaging (EPI) sequence optimized for the 
mouse olfactory bulb. Imaging parameters were set as 
follows: TR=3000 ms, TE=36 ms, FOV=2 × 2 cm2, matrix 
size=128 × 128, 12 transversal 0.5 mm thick slices and 
8 EPI segments. Diffusion images were acquired in 12 
non‑collinear directions with a b‑value of 750 s/mm2 
(3 b0 images were acquired). DTI derived maps, Frac‑
tional Anisotropy (FA), Apparent Diffusion Coefficient 
(ADC), Axial Diffusivity (AD) and Radial Diffusivity 
(RD), were calculated with Paravison 5.1 (Bruker, Karl‑
sruhe, Germany). Images showed no obvious distortion 
in the area of interest; hence a distortion correction 
procedure was not applied. 
Comparison between the two groups of mice was 
carried out with the Mann‐Whitney test. Results are 
presented as box‐and‐whiskers plots. Effect size (ES) 
was rated according to Cohen (1988) as follows: 0.2 
small, 0.5 medium, 0.8 large. Correlation analysis was 
carried out with Spearman rho.
RESULTS
One euploid mouse died during MRI and was dis‑
carded. Age was not significantly different in the two 
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groups of mice (P=0.204), with euploid showing higher 
body mass (P=0.011; ES=1.7) as previously found (Fruc‑
tuoso et al., 2017; Giacomini et al., 2018). Fig. 1 shows 
representative MRI images of euploid and trisomic 
Ts65Dn mouse head (Fig. 1A and 1E, respectively) show‑
ing the area used for OB morphometry (Fig. 1B and 1F) 
and T2 maps (Fig. 1C, 1G) as well as FA (Fig. 1D, 1H). 
Results of MRI analysis of the olfactory bulb in trisomic 
and euploid Ts65Dn mice are presented in Fig. 2. 
OB volume was reduced in trisomic vs. euploid mice, 
the difference being statistically significant, P=0.011, 
ES=1.7 (Fig. 2A). Mean absolute T2 value appeared high‑
er in trisomic mice as well, the difference being not 
significant (P=0.203 with a medium ES=0.7; Fig. 2B). All 
DTI variables did not differ in the two groups of mice 
(P>0.05, Fig. 2C‑F). 
Correlation analysis in the whole sample of Ts65Dn 
mice (n=15) showed statistically significant association 
between age and body mass (rho=0.74, P=0.01), while age 
was not correlated with OB volume (rho=0.09, P=0.742). 
T2 significantly correlated in a negative way with both 
age (rho=‑0.866, P<0.001) and body mass (rho=‑0.635, 
P=0.011). After adjusting for body mass, the negative 
association between age and T2 maps was maintained 
(rho=‑0.862, P<0.001). No significant correlation was 
found between DTI variables and age or body mass.
DISCUSSION
In this work, we explored by means of MRI some 
structural and functional characteristics of the OB in 
trisomic Ts65Dn mice and compared them with euploid 
individuals of the same strain. 
To the best of our knowledge, OB volume in DS has 
not been investigated in vivo. In this work, we found 
that OB volume is significantly lower in trisomic mice 
with a large ES. This is of special interest insofar over‑
all brain size/volume is similar in trisomic and euploid 
Ts65Dn mice (Davisson et al., 1993; Galdzicki et al., 2001; 
Aldridge et al., 2007; Roubertoux et al., 2017). Intrigu‑
ingly, the trisomic OB was about 87% the euploid, a re‑
duction superimposable to that found in the cerebel‑
lum (about 88%; Baxter et al., 2000). This suggests that 
trisomy especially affects the OB, making this brain 
structure of particular interest for investigating the 
neurofunctional correlates of DS. In humans, OB vol‑
ume is associated with olfactory function and decreas‑
es with age (Buschhutter et al., 2008). Noticeably, DS is 
characterized by accelerated aging and the same has 
been found in the Ts65Dn mouse (Vacano et al., 2012). 
Given the olfactory deficit in DS, it could be hypothe‑
sized that reduced OB volume in the Ts65Dn mouse is 
related to both accelerated aging and reduced olfactory 
function. This hypothesis is supported by data showing 
olfactory impairment in the adult Ts65Dn mouse (Guidi 
et al., 2017). Interestingly, reduced OB volume is also 
found in neurological diseases like migraine (Aktürk et 
al., 2019), depression (Rottstädt et al., 2018) and Par‑
kinson’s disease (Li et al., 2016), as well as in non‑neu‑
rological conditions like rheumatoid arthritis (Sayilir 
et al., 2019) and fibromyalgia (Sayilir et al., 2017), sug‑
gesting that OB volume may be related to a variety of 
pathological stimuli. Further, cell cycle alteration and 
decreased cell proliferation has been found in brain re‑
gions different from the OB in the Ts65Dn mouse (Con‑
testabile et al., 2007), which could contribute to reduc‑
tion in OB volume. This prompts for future in vivo and 
ex vivo investigations linking OB volume and structural 
changes therein.
T2 maps are able to provide information on the sta‑
tus of water in the brain (Eis et al, 1995). Longer T2 
maps values have been associated with edema (Elling‑
son et al., 2015), microstructural brain damage (Weis‑
senborn et al., 2013), and myelination disorders (Lee et 
al., 1998; Ding et al., 2008). We herein found that mean 
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Fig. 1. Representative axial MRI pictures of Ts65Dn mouse head. A‑D: euploid mouse. E‑H: trisomic mouse. In panels A and E, the olfactory bulb and some 
other regional structures are indicated. The framed area in panels B and F was used for olfactory bulb morphometry. Panels C and G show T2 maps. Panels 
D and H are fractional anisotropy images.
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absolute T2 maps value is about 8% higher in the OB of 
trisomic Ts65Dn mice. The difference was not statisti‑
cally significant, probably due to the limited number 
of mice in analysis; it was, however, associated with 
a medium ES (0.7). ES is considered a finding of sub‑
stantive significance (Cohen, 1988) and is independent 
of sample size. As a suggestion for future studies, we 
indicate that changes in the brain parenchyma may 
be to some extent present therein, albeit the differ‑
ence in T2 maps values of trisomic vs. euploid mice was 
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Fig. 2. Quantitative MRI variables in the olfactory bulb (OB) of trisomic Ts65Dn and euploid mice. A: OB volume is significantly smaller in trisomic mice. No 
difference is apparent in T2 (B), FA (C), ADC (D), AD (E) and RD (F). FA: fractional anisotropy, ADC: apparent diffusion coefficient, AD: axial diffusivity, RD: 
radial diffusivity. *: P<0.05.
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not statistically significant. The finding of similar DTI 
variables values in euploid and trisomic mice suggests 
that edema, instead of changes in tissue organization 
and/or myelin ensheathing of axons had taken place in 
OB. It would be expected that, in the presence of ede‑
ma, consensual changes in T2 maps value and ADC take 
place since ADC (also called mean diffusivity) is direc‑
tion‑independent, reflecting the total amount of water 
diffusivity in a voxel. Freedom of water diffusion and 
lower tissue density contribute to higher ADC (Assaf et 
al., 2008). Nevertheless, ADC values were similar in the 
two groups of mice. However, it should be underlined 
that T2 maps have a better signal‑to‑noise ratio than 
DTI measurements and accordingly show increased 
sensitivity (Petiet et al., 2016). This may explain such 
a discrepancy. Further work in a larger number of mice 
will better characterize DTI pattern in the OB of the 
Ts65Dn mouse, with the aim at identifying more sub‑
tle changes therein. In fact, DTI is considered a micro‑
structural probe operating on the micron scale (Basser 
et al., 2002), able to evaluate the structural integrity 
of nervous tissue, showing high concordance with the 
pathways defined in histological tracer‑injection stud‑
ies (Dyrby et al., 2011). In particular, fractional anisot‑
ropy (FA) is a measure of the relative diffusion along 
versus across fiber tracts, 0 value meaning completely 
isotropic diffusion and values close to 1 representing 
diffusion restricted to one direction (Westlin et al., 
2002). FA decrease is typically dependent on the num‑
ber and density of axons and is associated with neu‑
rodegenerative changes. AD is also related to axonal 
damage and fragmentation (Beaulieu et al., 1994). Ac‑
cordingly, FA and AD are considered as markers of axo‑
nal damage. RD is related to the radial diffusivity per‑
pendicular to white matter fascicles, hence changes 
in RD values are representative of axonal density and 
diameter, and myelination; RD is considered a marker 
of myelin damage.
In the whole sample of Ts65Dn mice (n=15), the find‑
ing of a negative correlation between age and T2 of the 
olfactory bulb is supported by similar findings in the 
gray matter of normal aging brain in both humans and 
other species (Dhenain et al., 1997; Falangola et al., 2007; 
Siemonsen et al., 2008; Kumar et al., 2011; Callaghan et 
al., 2014). This is possibly explained by hemosiderin 
deposition in gray matter during the aging process.
CONCLUSIONS
Overall, the current findings show that nervous tis‑
sue alterations are detectable in vivo in the OB of the 
Ts65Dm mouse, an animal model of DS, which are pos‑
sibly related to the olfactory deficit previously found 
in these mice. While results need to be confirmed in 
a larger number of mice and corroborated with ex‑vivo 
morphological techniques, it is suggested that quan‑
titative MRI is a valuable tool to identify trisomy‑as‑
sociated characteristics in mouse model of DS. Being 
non‑invasive, MRI can be used for repeated measure‑
ment in the same individual, thereby allowing for lon‑
gitudinal studies of the OB in DS mice.
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